Inhibitor Report for: Cisatracurium
Cisatracurium | Type (6) |
| Other_Name | cisatracurium besylate |
| | 3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate |
| Chemical_Nomenclature | 5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl |
| Formula | C53H72N2O12 |
| CAS_number | 96946-42-8 |
| MW | 929.14 |
| |
| Paper | Atherton_1999_Clin.Pharmacokinet_36_169 |
| | Diefenbach_1997_Anaesthesist_46_385 |
| | Nigrovic_1997_Anaesthesist_46_282 |
| Comment | Neuromuscular Nondepolarizing Agent, Nicotinic Antagonist, Neuromuscular blocking agent, (close to doxacurium) Cisatracurium is the 1R-cis 1'R-cis isomer of atracurium. Atracurium and Cisatracurium undergo spontaneous non-organ-dependent Hofmann degradation at physiological pH and temperature |
| CID | 62887 |
| Family | BCHE |
| InChIKey | YXSLJKQTIDHPOT-LJCJQEJUSA-N |
| CanonicalSMILES | C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C |
| InChI | InChI=1S/C53H72N2O12/c1-54(22-18-38-32-48(62-7)50(64-9)34-40(38)42(54)28-36-14-16-44(58-3)46(30-36)60-5)24-20-52(56)66-26-12-11-13-27-67-53(57)21-25-55(2)23-19-39-33-49(63-8)51(65-10)35-41(39)43(55)29-37-15-17-45(59-4)47(31-37)61-6/h14-17,30-35,42-43H,11-13,18-29H2,1-10H3/q+2/t42-,43-,54-,55-/m1/s1 |
| Wikipedia | Cisatracurium_besilate |
|
|